Inhibikase Therapeutics (IKT) Gains from Investment Securities (2020 - 2021)
Inhibikase Therapeutics' (IKT) quarterly Gains from Investment Securities came in at $29839.0 in Q4 2021, up 109.75% year-on-year from $14226.1 in Q4 2020, and down 83.58% on a QoQ basis from $181762.0 in Q3 2021.
Inhibikase Therapeutics (IKT) Gains from Investment Securities (2020 - 2021) Analysis & Trends
Inhibikase Therapeutics (IKT) has 2 years of Gains from Investment Securities data on file, last reported at $29839.0 in Q4 2021.
- On a quarterly basis, Gains from Investment Securities rose 109.75% year-over-year to $29839.0 in Q4 2021; TTM through Sep 2022 was $29839.0, a 91.54% decrease from a year earlier, with the FY2021 full-year figure at $688784.0, up 226.67% from the prior year.
- Gains from Investment Securities for Q4 2021 stood at $29839.0, down from $181762.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for IKT reached as high as $239415.0 in Q2 2021 and fell as low as -$306075.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Inhibikase Therapeutics | 407.51 Mn | 237.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 29,839.00 |
| Dec 31, 2021 | 29,839.00 |
| Sep 30, 2021 | 181,762.00 |
| Sep 30, 2021 | 181,762.00 |
| Jun 30, 2021 | 239,415.00 |
| Jun 30, 2021 | 239,415.00 |
| Mar 31, 2021 | 237,768.00 |
| Mar 31, 2021 | 237,768.00 |
| Dec 31, 2020 | -306,075.00 |
| Dec 31, 2020 | -306,075.00 |
| Sep 30, 2020 | 236,415.00 |
| Sep 30, 2020 | 236,415.00 |
| Jun 30, 2020 | 89,515.00 |
| Jun 30, 2020 | 89,515.00 |
| Mar 31, 2020 | 190,993.00 |
| Mar 31, 2020 | 190,993.00 |